Two Shot Same Day Exception Rules for COVID-19
For COVID-19 shots administered:
General rules are not series-specific; general rules apply to the entire vaccine group.
Rules for Recommending at the CVX Code vs. Vaccine Group Level
Series Completion Special Rule
Rules for an Additional Dose1
Rules for Booster Dose2Any of the FDA-Approved COVID-19 vaccines (except CVX 218) can be used for booster vaccination, regardless of the vaccine product used for primary vaccination. When a heterologous or “mix and match” booster dose is administered, the eligible population and dosing intervals are those of the vaccine used for primary vaccination. Recommendation Rules for Booster Dose
Evaluation Rules for Booster Dose
Rules for Extra Shots After Additional Dose1and/or Booster Doses2
|
Notes
|
CVX Code | Name | Absolute Minimum Age | Absolute Maximum Age | Counts towards U.S. Vaccination |
---|---|---|---|---|
207 | Moderna COVID-19 Vaccine | 0 days | Yes | |
208 | Pfizer COVID-19 Vaccine | 0 days | Yes | |
210 | AstraZeneca COVID-19 Vaccine | 0 days | Yes, only if all recommended doses are administered. | |
211 | Novavax COVID-19 Vaccine | 0 days | Yes, only if all recommended doses are administered. | |
212 | Janssen COVID-19 Vaccine | 0 days | Yes | |
213 | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | 0 days | Yes | |
217 | Pfizer COVID-19 Vaccine | 0 days | Yes | |
218 | Pfizer COVID-19 Vaccine (5-11 years) | 0 days | 18 years - 1 day | Yes |
219 | Pfizer COVID-19 Vaccine (Preferable age range: >= 6 months to < 5 years) | 0 days | 6 years - 1 day | Yes |
221 | Moderna COVID-19 Vaccine (Preferable age ranges: >= 6 years to < 12 years OR >= 18 years) | 0 days | Yes | |
227 | Moderna COVID-19 Vaccine (Inactive) | 0 days | 13 years - 1 day | Yes |
228 | Moderna COVID-19 Vaccine (Preferable age range: >= 6 months to < 6 years) | 0 days | 7 years - 1 day | Yes |
500 | COVID-19 Non-US Vaccine, Product Unknown | No | ||
501 | COVID-19 IV Non-US Vaccine (QAZCOVID-IN) | No | ||
502 | COVID-19 IV Non-US Vaccine (COVAXIN) | 0 days | Yes, only if all recommended doses are administered. | |
503 | COVID-19 LAV Non-US Vaccine (COVIVAC) | No | ||
504 | COVID-19 VVnr Non-US Vaccine (Sputnik Light) | No | ||
505 | COVID-19 VVnr Non-US Vaccine (Sputnik V) | No | ||
506 | COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology) | No | ||
507 | COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbology Chinese academy of Sciences) | No | ||
508 | COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) | No | ||
509 | COVID-19 PS Non-US Vaccine (EpiVacCorona) | No | ||
510 | COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) | 0 days | Yes, only if all recommended doses are administered. | |
511 | COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) | 0 days | Yes, only if all recommended doses are administered. | |
512 | COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) | 18 years - days | Yes, only if all recommended doses are administered. | |
513 | COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) | No | ||
514 | COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) | No | ||
515 | COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) | No | ||
516 | COVID-19 Inactivated Non-US Vaccine (Minhai Biotechnology Co, KCONVAC) | No | ||
517 | COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) | No |
No combination vaccines exist, at this time, that include COVID-19 and count toward completion of the Pfizer COVID-19 2-dose series.
CVX Code Specific RulesCVX Code Absolute Minimum Age
CVX Code Absolute Maximum Age
Absolute Minimum Interval Rule for Moderna Vaccines
Rule for CVX 213
Rules for COVID-19 Vaccines Not Authorized by FDA2The following set of rules apply to 1) COVID-19 Vaccines Not Authorized by FDA, but Authorized by WHO and, 2) COVID-19 Vaccines Not Authorized by FDA or WHO, but is an Active COVID-19 Vaccine Candidate as part of a U.S.-based Clinical Trial of a COVID-19 Vaccine.
|
Notes
|
Series Name
Series Selection RulesThere are four series for this vaccine group: the Pfizer COVID-19 series, Moderna COVID-19 series, Mixed Product COVID-19 series and the Janssen COVID-19 1-dose series. The rules for determining which series applies are:
|
The Pfizer COVID-19 Child (6 months - 17 years) Series is complete after 2 or 3 doses, depending on age (not including booster dose(s)).
Dose | Series Name | Absolute Minimum Age | Minimum Age | Routine Age | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Pfizer COVID-19 Series | 0 days | 6 months | 6 months | N/A | 208, 217, 218, 219 | N/A |
2 | Pfizer COVID-19 Series | 0 days | 6 months | 6 months | N/A | 208, 217, 218, 219 | N/A |
3 | Pfizer COVID-19 Series | 0 days | 6 months | 6 months | N/A | 208, 217, 218, 219 | N/A |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Pfizer COVID-19 Series | 17 days | 21 days | 21 days | N/A |
Dose 2 to 3 | Pfizer COVID-19 Series | 8 weeks - 4 days | 8 weeks | 8 weeks | N/A |
Series Special Rules
Vaccine to Recommend
Skip Dose Rule
Rule for CVX 218
Rule for CVX 212 (Janssen COVID-19 Vaccine)
|
The Pfizer COVID-19 Child (5-17) 2-dose Series is complete after 2 doses.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Moderna COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 221, 227, 228 | N/A |
2 | Moderna COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 221, 227, 228 | N/A |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | 0 days if dose 2 administer < 10/25/2021 24 days if dose 2 administered >= 10/25/2021 | 24 days | 28 days | 28 days | N/A |
Series Special Rules
Vaccine to Recommend
Rule for CVX 212 (Janssen COVID-19 Vaccine)
|
The Pfizer COVID-19 2-dose series is complete after 2 doses.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Mixed Product COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 208, 213, 217, 218, 219, 221, 227, 228 | N/A |
2 | Mixed Product COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 208, 213, 217, 218, 219, 221, 227, 228 | N/A |
3 | Mixed Product COVID-19 Series | 0 days | 6 months | 6 months | N/A | 207, 208, 213, 217, 218, 219, 221, 227, 228 | N/A |
Vaccine Dose Parameters - Minimum and Recommended Intervals
Doses | Series Name | Absolute Minimum Interval | Minimum Interval | Minimum Recommended Interval | Latest Recommended Interval (less than) |
---|---|---|---|---|---|
Dose 1 to 2 | Mixed Product COVID-19 Series | 0 days if dose 2 administered < 10/25/2021 24 days if dose 2 administered >= 10/25/2021 | 28 days | 28 days | N/A |
Dose 2 to 3 | Mixed Product COVID-19 Series | 8 weeks - 4 days | 8 weeks | 8 weeks | N/A |
Series Special Rules
Vaccine to Recommend
Skip Dose Rule
Rule for CVX 218
Rule for CVX 212 (Janssen COVID-19 Vaccine)
|
The Janssen COVID-19 1-dose Series is complete after 1 dose.
Vaccine Dose Parameters - Minimum and Routine Ages
Dose | Series Name | Absolute Minimum | Minimum Age | Routine | Latest Recommended Age (less than) | Valid CVX Code(s) per Dose for this Series | Invalid CVX Code(s) per Dose for this Series |
---|---|---|---|---|---|---|---|
1 | Janssen COVID-19 1-dose Series | 0 days | 18 years | 18 years | N/A | 212 | N/A |
Series Special Rules
|